Risk of colorectal carcinoma in post-liver transplant patients: A systematic review and meta-analysis

American Journal of Transplantation

Volumn 10, Issue 4, 2010, Pages 868-876

  Sint Nicolaas, Jerome ^a   De Jonge, V ^a   Steyerberg, E W ^a   Kuipers, E J ^a   Van Leerdam, M E ^a   Veldhuyzen Van Zanten, S J O ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

Author keywords

Colorectal cancer; Incidence rate; Liver transplantation; Primary sclerosing cholangitis; Relative risk; Surveillance

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; COLORECTAL CARCINOMA; HIGH RISK PATIENT; HUMAN; LIVER TRANSPLANTATION; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; POPULATION RESEARCH; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; SCREENING TEST; TREATMENT RESPONSE;

COLORECTAL NEOPLASMS; HUMANS; LIVER TRANSPLANTATION; RISK FACTORS;

EID: 77949785317     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03049.x     Document Type: Article

References (71)

1. Fung JJ, Jain A, Kwak EJ, Kusne S, Dvorchik I, Eghtesad B. De novo malignancies after liver transplantation: A major cause of late death. Liver Transplant 2001 7 (11 Suppl 1 S109 118.
2. Jain AB, Yee LD, Nalesnik MA et al. Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation 1998 66 : 1193 1200.
3. Oo YH, Gunson BK, Lancashire RJ, Cheng KK, Neuberger JM. Incidence of cancers following orthotopic liver transplantation in a single center: Comparison with national cancer incidence rates for England and Wales. Transplantation 2005 80 : 759 764.
4. Vallejo GH, Romero CJ, de Vicente JC. Incidence and risk factors for cancer after liver transplantation. Crit Rev Oncol Hematol 2005 56 : 87 99.
5. Silva MA, Jambulingam PS, Mirza DF. Colorectal cancer after orthotopic liver transplantation. Crit Rev Oncol Hematol 2005 56 : 147 153.
6. Haagsma EB, Hagens VE, Schaapveld M et al. Increased cancer risk after liver transplantation: A population-based study. J Hepatol 2001 34 : 84 91.
7. Buell JF, Papaconstantinou HT, Skalow B, Hanaway MJ, Alloway RR, Woodle ES. De novo colorectal cancer: Five-year survival is markedly lower in transplant recipients compared with the general population. Transplant Proc 2005 37 : 960 961.
8. Knechtle SJ, D'Alessandro AM, Harms BA, Pirsch JD, Belzer FO, Kalayoglu M. Relationships between sclerosing cholangitis, inflammatory bowel disease, and cancer in patients undergoing liver transplantation. Surgery 1995 118 : 615 619 discussion 9 20.
9. Brentnall TA, Haggitt RC, Rabinovitch PS et al. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1996 110 : 331 338.
10. van de Vrie W, de Man RA, van Buuren HR, Schouten WR, Tilanus HW, Metselaar HJ. Inflammatory bowel disease and liver transplantation for primary sclerosing cholangitis. Eur J Gastroenterol Hepatol 2003 15 : 657 663.
11. Bleday R, Lee E, Jessurun J, Heine J, Wong WD. Increased risk of early colorectal neoplasms after hepatic transplant in patients with inflammatory bowel disease. Dis Colon Rectum 1993 36 : 908 912.
12. Broome U, Lofberg R, Lundqvist K, Veress B. Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis. Dis Colon Rectum 1995 38 : 1301 1315.
13. Eaden JA, Mayberry JF. Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut 2002 51 (Suppl 5 V10 12.
14. Collins PD, Mpofu C, Watson AJ, Rhodes JM. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease. Cochrane database of systematic reviews (online). 2006 CD000279.
15. Wells GSB, Shea B, O'Connell D et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Health Research Institute Web site [cited June 3 2008.]; available from http://www.ohri.ca/programs/clinical-epidemiology/oxford.htm.
16. Sint Nicolaas J, Tjon SW, Metselaar HJ, Kuipers EJ, De Man RA, van Leerdam ME. W1991 Is colonoscopy screening mandatory for post-Ltx recipients? Gastroenterology 2009 : A-768.
17. Sutton AJAK, Jones DR. Methods for meta-analysis in medical research. John Wiley & Sons, 2000.
18. Yousef F, Cardwell C, Cantwell MM, Galway K, Johnston BT, Murray L. The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: A systematic review and meta-analysis. Am J Epidemiol 2008 168 : 237 249.
19. Ries LAG MD, Krapcho M, Stinchcomb DG et al. eds. SEER Cancer Statistics Review, 1975 2005, Bethesda, MD : National Cancer Institute. Based on November 2007 SEER data submission, posted to the SEER web site, 2008. Available from http://seer.cancer.gov/csr/1975-2005/
20. Steyerberg EW, Kievit J, de Mol Van Otterloo JC, van Bockel JH, Eijkemans MJ, Habbema JD. Perioperative mortality of elective abdominal aortic aneurysm surgery. A clinical prediction rule based on literature and individual patient data. Arch Intern Med 1995 155 : 1998 2004.
21. Efron B. Bootstrap methods: another look at the jackknife. Ann Stat 1979 7 : 1 26.
22. DerSimonian R, Kacker R. Random-effects model for meta-analysis of clinical trials: An update. Contemp Clin Trials 2007 28 : 105 114.
23. Hatala R, Keitz S, Wyer P, Guyatt G. Tips for learners of evidence-based medicine: 4. Assessing heterogeneity of primary studies in systematic reviews and whether to combine their results. CMAJ 2005 172 : 661 665.
24. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997 315 : 629 634.
25. Stata Corporation, College Station, Texas. Available from http://www.stata.com.
26. Penn I. Cancer in the immunosuppressed organ recipient. Transplant Proc 1991 23 : 1771 1772.
27. Vera A, Gunson BK, Ussatoff V et al. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis. Transplantation 2003 75 : 1983 1988.
28. Levy MBL, Husberg B, Goldstein R, McMillan R, Gibbs J. De novo malignancy following liver transplantation: A single center study. Transplant Proc 1993 25 : 1397 1399.
29. Frezza EE, Fung JJ, van Thiel DH. Non-lymphoid cancer after liver transplantation. Hepato gastroenterol 1997 44 : 1172 1181.
30. Fabia R, Levy MF, Testa G et al. Colon carcinoma in patients undergoing liver transplantation. Am J Surg 1998 176 : 265 269.
31. Herrero JI, Lorenzo M, Quiroga J et al. De Novo neoplasia after liver transplantation: an analysis of risk factors and influence on survival. Liver Transplant 2005 11 : 89 97.
32. Sheiner PA, Magliocca JF, Bodian CA et al. Long-term medical complications in patients surviving > or = 5 years after liver transplant. Transplantation 2000 69 : 781 789.
33. Menachem Y, Safadi R, Ashur Y, Ilan Y. Malignancy after liver transplantation in patients with premalignant conditions. J Clin Gastroenterol 2003 36 : 436 439.
34. Bellamy CO, DiMartini AM, Ruppert K et al. Liver transplantation for alcoholic cirrhosis: Long term follow-up and impact of disease recurrence. Transplantation 2001 72 : 619 626.
35. Sanchez EQ, Marubashi S, Jung G et al. De novo tumors after liver transplantation: A single-institution experience. Liver Transplant 2002 8 : 285 291.
36. Kelly DM, Emre S, Guy SR, Miller CM, Schwartz ME, Sheiner PA. Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors. Cancer 1998 83 : 1237 1243.
37. Herrero JI, Lorenzo M, Quiroga J et al. Usefulness of a program of neoplasia surveillance in liver transplantation. A preliminary report. Clin Transplant 2009 23 : 532 536.
38. Penn I. Posttransplantation de novo tumors in liver allograft recipients. Liver Transplant Surg 1996 2 : 52 59.
39. Safadi R, Ilan Y, Eid A et al. Solid tumors after liver transplantation. Transplant Proc 1999 31 : 1894 1895.
40. Aberg F, Pukkala E, Hockerstedt K, Sankila R, Isoniemi H. Risk of malignant neoplasms after liver transplantation: A population-based study. Liver Transplant 2008 14 : 1428 1436.
41. Jonas S, Rayes N, Neumann U et al. De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin. Cancer 1997 80 : 1141 1150.
42. Peyregne V, Ducerf C, Adham M et al. De novo cancer after orthotopic liver transplantation. Transplant Proc 1998 30 : 1484 1485.
43. Xiol X, Guardiola J, Menendez S et al. Risk factors for development of de novo neoplasia after liver transplantation. Liver Transplant 2001 7 : 971 975.
44. Saigal S, Norris S, Muiesan P, Rela M, Heaton N, O'Grady J. Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Liver Transplant 2002 8 : 482 487.
45. Benlloch S, Berenguer M, Prieto M et al. De novo internal neoplasms after liver transplantation: Increased risk and aggressive behavior in recent years? Am J Transplant 2004 4 : 596 604.
46. Aseni P, Vertemati M, De Carlis L et al. De novo cancers and post-transplant lymphoproliferative disorder in adult liver transplantation. Pathol Int 2006 56 : 712 715.
47. Aigner F, Boeckle E, Albright J et al. Malignancies of the colorectum and anus in solid organ recipients. Transplant Int 2007 20 : 497 504.
48. Koornstra JJ, Wesseling J, de Jong AE, Vasen HF, Kleibeuker JH, Haagsma EB. Increased risk of colorectal neoplasia in asymptomatic liver-transplant recipients. Gut 2007 56 : 892 893.
49. Johnson EE, Leverson GE, Pirsch JD, Heise CP. A 30-year analysis of colorectal adenocarcinoma in transplant recipients and proposal for altered screening. J Gastrointest Surg 2007 11 : 272 279.
50. Dumortier J, Guillaud O, Adham M et al. Negative impact of de novo malignancies rather than alcohol relapse on survival after liver transplantation for alcoholic cirrhosis: A retrospective analysis of 305 patients in a single center. Am. J Gastroenterol 2007 102 : 1032 1041.
51. Jiang Y, Villeneuve PJ, Fenton SS, Schaubel DE, Lilly L, Mao Y. Liver transplantation and subsequent risk of cancer: findings from a Canadian cohort study. Liver Transplant 2008 14 : 1588 1597.
52. Baccarani U, Adani GL, Montanaro D et al. De novo malignancies after kidney and liver transplantations: Experience on 582 consecutive cases. Transplant Proc 2006 38 : 1135 1137.
53. Boin I, Leonardi MI, Stucchi RB et al. De novo posttransplantation nonlymphoproliferative malignancies in liver transplant recipients. Transplant Proc 2007 39 : 3284 3286.
54. Sheil AG. Malignancy following liver transplantation: A report from the Australian Combined Liver Transplant Registry. Transplant Proc 1995 27 : 1247.
55. Catena F, Nardo B, Liviano d'Arcangelo G et al. De novo malignancies after organ transplantation. Transplant Proc 2001 33 : 1858 1859.
56. Jimenez C, Rodriguez D, Marques E et al. De novo tumors after orthotopic liver transplantation. Transplant Proc 2002 34 : 297 298.
57. Schmilovitz-Weiss H, Mor E, Sulkes J et al. De novo tumors after liver transplantation: A single-center experience. Transplant Proc 2003 35 : 665 666.
58. Romero-Vargas ME, Flores-Cortes M, Valera Z et al. Cancers of new appearance in liver transplant recipients: Incidence and evolution. Transplant Proc 2006 38 : 2508 2510.
59. Galve ML, Cuervas-Mons V, Figueras J et al. Incidence and outcome of de novo malignancies after liver transplantation. Transplant Proc 1999 31 : 1275 1277.
60. Jain A, Nalesnik M, Reyes J et al. Posttransplant lymphoproliferative disorders in liver transplantation: A 20-year experience. Ann Surg 2002 236 : 429 436 discussion 36 37.
61. Dhillon MS, Rai JK, Gunson BK, Olliff S, Olliff J. Post-transplant lymphoproliferative disease in liver transplantation. Br J Radiol 2007 80 : 337 346.
62. Di Benedetto F, Di Sandro S, De Ruvo N et al. Kaposi's sarcoma after liver transplantation. J Cancer Res Clin Oncol 2008 134 : 653 658.
63. Gruber SA, Matas AJ. Etiology and pathogenesis of tumors occurring after organ transplantation. Transplant Sci 1994 4 : 87 104.
64. Selgrad M, Koornstra JJ, Fini L et al. JC virus infection in colorectal neoplasia that develops after liver transplantation. Clin Cancer Res 2008 14 : 6717 6721.
65. Rudraraju M, Osowo AT, Singh V, Carey EJ. Do patients need more frequent colonoscopic surveillance after liver transplantation? Transplant Proc 2008 40 : 1522 1524.
66. Atassi T, Thuluvath PJ. Risk of colorectal adenoma in liver transplant recipients compared to immunocompetent control population undergoing routine screening colonoscopy. J Clin Gastroenterol 2003 37 : 72 73.
67. Dutch Comprehensive Cancer Registry. 2005 [cited 2008 20-11]; available from http://www.ikcnet.nl/uploaded/FILES/Landelijk/cijfers/incidentie%202008/ A4(a4a)%202005%20ka.xls
68. Irwig L, Macaskill P, Berry G, Glasziou P. Bias in meta-analysis detected by a simple, graphical test. Graphical test is itself biased. BMJ 1998 316 : 470 author reply -1.
69. Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol 2001 96 : 2992 3003.
70. Butterworth AS, Higgins JP, Pharoah P. Relative and absolute risk of colorectal cancer for individuals with a family history: A meta-analysis. Eur J Cancer 2006 42 : 216 227.
71. Winawer S, Fletcher R, Rex D et al. Colorectal cancer screening and surveillance: Clinical guidelines and rationale-Update based on new evidence. Gastroenterology 2003 124 : 544 560.